Versant Capital Management Inc Has $85,000 Stock Holdings in The Clorox Company (NYSE:CLX)

Versant Capital Management Inc boosted its stake in shares of The Clorox Company (NYSE:CLXFree Report) by 45.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 521 shares of the company’s stock after buying an additional 162 shares during the period. Versant Capital Management Inc’s holdings in Clorox were worth $85,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the stock. Principal Financial Group Inc. raised its holdings in shares of Clorox by 6.9% during the third quarter. Principal Financial Group Inc. now owns 151,257 shares of the company’s stock worth $24,641,000 after acquiring an additional 9,720 shares during the period. Inspire Trust Co. N.A. raised its stake in shares of Clorox by 5.9% in the 3rd quarter. Inspire Trust Co. N.A. now owns 17,827 shares of the company’s stock valued at $2,904,000 after purchasing an additional 1,000 shares during the period. Franklin Resources Inc. lifted its holdings in shares of Clorox by 10.4% in the third quarter. Franklin Resources Inc. now owns 135,225 shares of the company’s stock valued at $21,840,000 after purchasing an additional 12,776 shares in the last quarter. Tidal Investments LLC boosted its position in shares of Clorox by 1.3% during the third quarter. Tidal Investments LLC now owns 29,913 shares of the company’s stock worth $4,873,000 after buying an additional 393 shares during the period. Finally, Wilmington Savings Fund Society FSB grew its holdings in shares of Clorox by 12.5% during the third quarter. Wilmington Savings Fund Society FSB now owns 10,366 shares of the company’s stock worth $1,689,000 after buying an additional 1,150 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Wall Street Analyst Weigh In

CLX has been the subject of a number of recent research reports. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and upped their price target for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. DA Davidson increased their target price on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Evercore ISI lowered their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research note on Monday, October 14th. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday. Finally, Barclays lifted their target price on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research report on Friday, November 1st. Five equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $155.38.

Read Our Latest Stock Analysis on CLX

Clorox Stock Performance

CLX opened at $162.89 on Friday. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The business has a 50 day moving average of $164.58 and a 200-day moving average of $154.79. The stock has a market cap of $20.16 billion, a price-to-earnings ratio of 56.76, a PEG ratio of 3.04 and a beta of 0.42.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company’s quarterly revenue was up 27.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.49 EPS. On average, equities research analysts expect that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 3.00%. Clorox’s dividend payout ratio is currently 170.03%.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.